Human Papilloma Virus (HPV) Vaccine

Overview

The HPV vaccines work like other immunizations that guard against viral infection. The investigators hypothesized that the unique surface components of HPV might create an antibody response that is capable of protecting the body against infection and that these components could be used to form the basis of a vaccine. These surface components can interact with one another to form virus-like particles (VLP) that are noninfectious and stimulate the immune system to produce antibodies that can prevent the complete papillomavirus from infecting cells.

Categories

• 19 Immunologicals
  • 19.3 Vaccines
  • 19.3.1 Vaccines for universal immunization

Page headings

Primary Characterstics

Indications

Pharmacokinetics

Contraindications

Drug Interactions

Side Effects

The symptomatic adverse reactions produced by Human Papilloma Virus (HPV) Vaccine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Fever, Itching, Swelling, Mild soreness at the injection site, Redness at injection site, dizziness.

Dosage

Human Papilloma Virus (HPV) Vaccine's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
0.5 mL	0.5 (0.5)	As recommended.	IM	Between 10 to 25 years for prevention of cervical cancer.
0.5 mL	0.5 (0.5)	As recommended.	IM	Usual Adult Dose for Human Papillomavirus Prophylaxis: Repeat dose in 2 months and 6 months for a total of 3 doses. (Between 9 to 26 years)
Paedriatic Dosage (20kg)
No data regarding the Paedriatic dosage details of Human Papilloma Virus (HPV) Vaccine is available.
Neonatal Dosage (3kg)
No data regarding the neonatal dosage details of Human Papilloma Virus (HPV) Vaccine is available.

High Risk Groups

Warning / Precautions

Storage Conditions

Interference in Pathology

Brands / Trade Names of Human Papilloma Virus (HPV) Vaccine

Manufacturers of Human Papilloma Virus (HPV) Vaccine in Pakistan

Back to top